Related Experiment Video
Updated: Jul 1, 2025

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis
Published on: January 5, 2017
Dietary Magnesium Intake Is Inversely Associated With Ulcerative Colitis: A Case-Control Study
Omid Sadeghi1, Zeinab Khademi2, Parvane Saneei3,4
1Nutrition and Food Security Research Center, Department of Community Nutrition, Student Research Committee, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan, Iran.
Higher dietary magnesium intake may reduce the risk of developing ulcerative colitis (UC). This study found a significant inverse association between magnesium consumption and UC incidence in adults.
Area of Science:
- Gastroenterology
- Nutritional Science
- Epidemiology
Background:
- Ulcerative colitis (UC) is a chronic inflammatory bowel disease characterized by gut inflammation and ulceration.
- Limited data exist on the association between dietary magnesium and UC.
- This study investigates the link between magnesium intake and UC in adults.
Purpose of the Study:
- To examine the relationship between dietary magnesium intake and the prevalence of ulcerative colitis.
- To determine if magnesium consumption is a protective factor against UC development.
Main Methods:
- A population-based case-control study involving 109 UC patients and 218 matched controls.
- Dietary intake assessed using a validated Food Frequency Questionnaire (FFQ).
- Data on potential confounders collected via a pretested questionnaire.
Main Results:
- Individuals with the highest magnesium intake (top tertile) showed a lower likelihood of having UC compared to those with the lowest intake (bottom tertile).
- A significant inverse association was observed between dietary magnesium and UC (crude OR: 0.32, 95% CI: 0.18-0.59).
- This inverse relationship persisted after adjusting for potential confounders (adjusted OR: 0.30, 95% CI: 0.14-0.68).
Conclusions:
- A diet rich in magnesium may play a role in preventing ulcerative colitis.
- Further research is warranted to validate these findings and elucidate the underlying mechanisms.
More Related Videos
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Drugs for Treatment of Ulcerative Colitis in IBD

